Biometrics Built Better

Flexible teams, consistent thinking: The statistical solution biotechs need

Learn how embedded statistical support helps emerging biotechs bridge the gap between strategy and execution, providing continuous oversight, deeper program understanding, and expert guidance throughout clinical development.

Share this article

Most small and mid-sized biotechs are deliberately built to be agile, with lean internal teams and flexible access to external expertise as needs evolve. This model enables organizations to manage cost, move quickly and bring in specialized capability without committing to permanent headcount, which is critical in an environment where priorities can shift rapidly as data emerges. 

Against this backdrop, an important question starts to emerge. If your operating model is built around flexibility and external support, how do you ensure that the statistical thinking underpinning your program remains coherent over time?  

Balancing flexibility with continuity 

In practice, statistical input is often concentrated around key moments such as trial design, regulatory interactions and major readouts. However, decision-making does not stop between these points. Questions continue to arise, data accumulates and assumptions evolve. The challenge is not simply about when support is needed, but about how continuity is maintained between these moments. Without it, decisions risk being made in isolation, with limited connection to what has come before. 

Traditional models tend to provide input at specific points in time, leaving the space in between less well-defined. What is often missing is a consistent presence that carries thinking through the program, connecting detailed work with the broader context in which decisions are made. 

More than strategic. More than operational 

A second, equally important challenge lies not in timing, but in how statistical work is structured. It is often split between strategic input at key decision points and operational delivery during study execution. In reality, the value does not sit at either end of this spectrum. It lies in how ownership of thinking is maintained across these activities. Interpretation, assumptions and decisions made at a strategic level need to be applied at the operational level. 

When these activities are separated, even subtly, disconnects can emerge. Strategic intent is not always reflected in execution, and practical constraints may not fully inform earlier decisions. Over time, this can erode alignment across the program. The most effective statistical contribution sits across both domains, maintaining a clear link between high-level thinking and day-to-day delivery. 

A different type of outsourced biostatistics support 

This shifts the question from when or where support is needed, to who is responsible for maintaining continuity across the program. For many emerging biotechs, the most effective model is one which has a dedicated statistical partner who operates as an extension of the internal team. This is someone who understands the program in depth, including its history, its assumptions and the rationale behind key decisions. They are involved regularly enough to maintain context, but not necessarily full-time. Their role is not limited to delivering specific outputs, but extends to supporting the ongoing thinking of the program, whether that is reviewing data or analysis plans, overseeing CRO work, or contributing to discussions about design and interpretation. 

Importantly, decisions are shaped by a continuous understanding of the program, and this creates stability with a single statistical voice. 

Beyond the independent consultant model 

Independent consultants often represent a natural option for organizations seeking flexibility, particularly where strategic input is required. They can bring deep expertise and valuable perspective, especially at key inflection points in a program. 

However, this model also has its limitations. Consultants are typically engaged for specific pieces of work or high-level input, and while they may provide strong direction, they are less often embedded in the day-to-day detail of study delivery. This can create a gap between strategy and execution, where decisions are made at a high level but are not always consistently carried through or implemented into the operational aspects of the program. 

Consistency with depth through embedded support 

At its core is a single statistician that operates as an extension of the sponsor. For biotechs, this provides a single point of contact that performs as a contract statistician with the benefit of an internal team member throughout the program, offering continuity and building a deep understanding of its detail. This individual is visible within the sponsor’s team, participates in discussions and contributes to challenging decisions as a partner, rather than an external provider. 

At the same time, they are not a lone statistician. They are supported by a wider team with breadth of experience across methodologies, therapeutic areas and regulatory contexts. When more specialized input is required, it can be drawn in as needed, without disrupting the continuity of the relationship. 

From the perspective of the biotech, this creates the benefit of having a dedicated statistician embedded within the program, combined with access to a much broader base of expertise. It also means that processes, quality frameworks and ways of working are already established, reducing the need to build these elements internally. 

Biostatistics consulting for small biotechs 

CROs will always play a critical role in delivering the operational aspects of clinical trials, and independent consultants will continue to provide valuable expertise at key points. However, for many emerging biotechs, the most impactful support sits between these models. 

A consistent statistical partner who combines hands-on capability with strategic awareness, who operates as part of the team rather than outside of it, and who is supported by a wider network of expertise when required. This is not about increasing resource, but about how that resource is applied across the program, to ensure that statistical thinking remains aligned and carried through to the decisions that matter most. 

Ultimately, this is not just a question of statistical capability, but of the operating model design. The organizations that succeed are those where expertise is not simply accessed when needed, but fully embedded, creating the trust required for effective decision-making and delivery. 

To find out more about how an embedded statistician can support you, get in touch by clicking on the contact us button below.

Share this article

Stay Connected

Sign up to receive the latest insights, case studies, and Veramed news—straight to your inbox.

Related Posts